We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+12.45%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$22.1M
AUM Growth
+$1.61M
Cap. Flow
-$398M
Cap. Flow %
-1,799.52%
Top 10 Hldgs %
12.57%
Holding
3,425
New
197
Increased
908
Reduced
971
Closed
178

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$74.9M
2
PAYX icon
Paychex
PAYX
+$65.6M
3
PH icon
Parker-Hannifin
PH
+$56.9M
4
CNC icon
Centene
CNC
+$53.4M
5
SBUX icon
Starbucks
SBUX
+$47.3M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$84M
2
MAR icon
Marriott International
MAR
+$72.7M
3
GD icon
General Dynamics
GD
+$71.4M
4
CPAY icon
Corpay
CPAY
+$64.1M
5
ORCL icon
Oracle
ORCL
+$53.3M

Sector Composition

Rank Sector Weight
1 Technology 15.88%
2 Healthcare 13.59%
3 Financials 12.45%
4 Industrials 11.29%
5 Consumer Discretionary 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLB icon
1276
Dolby
DLB
$4.97B
$74 ﹤0.01%
1,176
+1,050
+833% +$67.1K
JD icon
1277
JD.com
JD
$42.9B
$74 ﹤0.01%
2,464
+114
+5% +$2.9K
MKL icon
1278
Markel Group
MKL
$25.5B
$74 ﹤0.01%
76
TU icon
1279
Telus
TU
$16.7B
$74 ﹤0.01%
4,000
LNG icon
1280
Cheniere Energy
LNG
$52.8B
$73 ﹤0.01%
1,075
-1,235
-53% -$81.2K
MER.PRK
1281
Bank of America Income Capital Obligation Notes due December 15 2066
MER.PRK
$1.06B
$73 ﹤0.01%
2,800
PTEN icon
1282
Patterson-UTI
PTEN
$3.48B
$73 ﹤0.01%
5,306
+467
+10% +$6.12K
HLIO icon
1283
Helios Technologies
HLIO
$2.56B
$72 ﹤0.01%
1,550
ORMP icon
1284
Oramed Pharmaceuticals
ORMP
$171M
$72 ﹤0.01%
20,000
RF.PRB
1285
DELISTED
REGIONS FINANCIAL CORPORATION
RF.PRB
$72 ﹤0.01%
2,715
+750
+38% +$20K
ANSS
1286
DELISTED
Ansys
ANSS
$71 ﹤0.01%
389
+144
+59% +$24.4K
EXEL icon
1287
Exelixis
EXEL
$14.2B
$71 ﹤0.01%
3,022
+2,982
+7,455% +$68K
IRBT
1288
DELISTED
iRobot
IRBT
$71 ﹤0.01%
610
-50
-8% -$5.32K
PBYI icon
1289
Puma Biotechnology
PBYI
$406M
$71 ﹤0.01%
1,854
PFI icon
1290
Invesco Dorsey Wright Financial Momentum ETF
PFI
$59.7M
$71 ﹤0.01%
2,141
FDL icon
1291
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.9B
$70 ﹤0.01%
2,354
IBN icon
1292
ICICI Bank
IBN
$109B
$70 ﹤0.01%
6,188
-187
-3% -$1.94K
ITB icon
1293
iShares US Home Construction ETF
ITB
$2.41B
$70 ﹤0.01%
2,000
NWE icon
1294
NorthWestern Energy
NWE
$4.45B
$70 ﹤0.01%
1,000
PRO
1295
DELISTED
PROS Holdings
PRO
$70 ﹤0.01%
1,675
+25
+2% +$949
CRC
1296
DELISTED
California Resources Corporation
CRC
$70 ﹤0.01%
2,766
MUFG icon
1297
Mitsubishi UFJ Financial
MUFG
$253B
$69 ﹤0.01%
13,982
-412
-3% -$2.14K
RSPH icon
1298
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$774M
$69 ﹤0.01%
3,500
ESE icon
1299
ESCO Technologies
ESE
$8.18B
$68 ﹤0.01%
1,017
-11
-1% -$737
PCRX icon
1300
Pacira BioSciences
PCRX
$1.05B
$68 ﹤0.01%
1,792

Similar funds

Glenmede Trust's Q1 2019 Portfolio in Review

As of Q1 2019, Glenmede Trust held 3,425 positions worth $22.1M, up 7.8% from $20.5M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust withdrew a net $398M in Q1 2019, closing 178 positions and reducing 971 holdings. Its most notable exit was Commercial Vehicle Group, an estimated $6.21K position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Commault Systems worth $25.2K.

  • Glenmede Trust's largest Q1 2019 buy was Commault Systems: 389,883 shares worth $25.2K.
  • Glenmede Trust added most to Accenture in Q1 2019, an estimated $74.9M increase.
  • Glenmede Trust's biggest Q1 2019 reduction was Walt Disney, cutting an estimated $84M.
  • Glenmede Trust fully exited Commercial Vehicle Group in Q1 2019, selling an estimated $6.21K.
  • Glenmede Trust's ten largest holdings make up 13% of its $22.1M portfolio in Q1 2019.
  • Glenmede Trust opened 197 new positions and closed 178 in Q1 2019.
  • Glenmede Trust's portfolio value rose 7.8% quarter-over-quarter to $22.1M.

Based on Glenmede Trust's 13F filing for Q1 2019, filed 14 May 2019.